SCHEMBL837372

SCHEMBL837372

O=C(O)/C=C/C(=O)N(O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.44
HCAR2 Q8TDS4 2/20 0.43
HDAC3 O15379 1/20 0.43
TNKS O95271 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 4/20 0.40
HPGD P15428 2/20 0.40
ALDH1A1 P00352 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3279797 1.00 TRPM8 (0.44) TRPM8HCAR2HDAC3TNKSHDAC4
SCHEMBL837373 1.00 TRPM8 (0.44) TRPM8HCAR2HDAC3TNKSHDAC4
SCHEMBL7456057 0.84 TRPM8 (0.42) TRPM8NPSR1MAPTKDM4EHPGD
SCHEMBL30764040 0.81 TRPM8 (0.66) TRPM8HCAR2HDAC3TNKSHDAC4
SCHEMBL836332 0.80 TRPM8 (0.70) TRPM8HCAR2HDAC3TNKSHDAC4
SCHEMBL836333 0.80 TRPM8 (0.70) TRPM8HCAR2HDAC3TNKSHDAC4
Maleic Acid SCHEMBL29875749 0.78 HCAR2 (0.50) TRPM8HCAR2HDAC3TNKSHDAC4
Fumaric Acid SCHEMBL21145268 0.78 HCAR2 (0.50) TRPM8HCAR2HDAC3TNKSHDAC4
Fumaric Acid SCHEMBL21145270 0.78 HCAR2 (0.50) TRPM8HCAR2HDAC3TNKSHDAC4
SCHEMBL4022487 0.78 LMNA (0.49) TRPM8HCAR2HDAC3TNKSHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143423-B2 N-heterocyclic carbene (NHC) catalyzed synthesis of hydroxamic acids AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2012-03-27 US disclosed
US-20100105921-A1 N-HETEROCYCLIC CARBENE (NHC) CATALYZED SYNTHESIS OF HYDROXAMIC ACIDS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105921-A1 N-HETEROCYCLIC CARBENE (NHC) CATALYZED SYNTHESIS OF HYDROXAMIC ACIDS NDC1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HAO2 TRPM8 4490/4885HCAR2 25/4885HDAC3 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.